Health Canada drug identification number

DIN 02496259 — SANDOZ POSACONAZOLE 100 MG

SANDOZ POSACONAZOLE is a tablet (delayed-release) of Posaconazole marketed by SANDOZ CANADA INCORPORATED. The full Posaconazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02496259
Brand name
SANDOZ POSACONAZOLE
Active ingredient
Posaconazole
Strength
100 MG
Dosage form
TABLET (DELAYED-RELEASE)
Route
ORAL
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Triazole antifungal agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Posaconazole products

DINBrandStrengthFormManufacturerStatus
02542021 GLN-POSACONAZOLE 100 MG TABLET (DELAYED-RELEASE) GLENMARK PHARMACEUTICALS CANADA INC. MARKETED
02530333 JAMP POSACONAZOLE 40 MG SUSPENSION JAMP PHARMA CORPORATION MARKETED
02544644 MINT-POSACONAZOLE 100 MG TABLET (DELAYED-RELEASE) MINT PHARMACEUTICALS INC MARKETED
02424622 POSANOL 100 MG TABLET (DELAYED-RELEASE) MERCK CANADA INC MARKETED
02293404 POSANOL 200 MG SUSPENSION MERCK CANADA INC MARKETED
02432676 POSANOL 300 MG SOLUTION MERCK CANADA INC MARKETED
02543311 TARO-POSACONAZOLE 100 MG TABLET (DELAYED-RELEASE) TARO PHARMACEUTICALS INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.